<DOC>
	<DOCNO>NCT02502409</DOCNO>
	<brief_summary>This study examine two group subject factor IX ( FIX ) deficiency : 1 ) current history inhibitor FIX , ; 2 ) group two affect brother , without inhibitor . The overall goal characterize study group term medical history , pattern bleeding , care , quality life , complication include development joint disease , inhibitory antibody FIX , use immune tolerance induction ( ITI ) outcome .</brief_summary>
	<brief_title>Natural History Study Factor IX Treatment Complications</brief_title>
	<detailed_description>Hemophilia B , FIX deficiency , second common type hemophilia , occur one 25,000 male birth . This disease way complex hemophilia A , less well understood . Differences include low incidence great risk side effect treatment , example , allergic reaction kidney disease . This study examine two group subject FIX deficiency - current history inhibitor FIX , group two affect brother , without inhibitor . The overall goal characterize study group term medical history , pattern bleeding , care , quality life , complication include development inhibitory antibody FIX , allergy , kidney , joint disease .</detailed_description>
	<mesh_term>Hemophilia B</mesh_term>
	<criteria>1 . A consent approved appropriate Institutional Review Board ( IRB ) /Independent Ethics Committee ( IEC ) obtain subject legally acceptable representative 2 . Subject FIX deficiency AND Is part affect brother pair/group also enroll ; AND/OR Has current history inhibitor , define &gt; 0.6 Bethesda unit ( BU ) 1 . Subject another congenital bleed disorder 2 . Subject carrier hemophilia B factor level &gt; 0.40 IU/mL</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Hemophilia B</keyword>
	<keyword>Hemophilia B Inhibitors</keyword>
</DOC>